Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mindin regulates fibroblast subpopulations through distinct Src family kinases during fibrogenesis
Sunny Kataria, Isha Rana, Krithika Badarinath, Rania F. Zaarour, Gaurav Kansagara, Sultan Ahmed, Abrar Rizvi, Dyuti Saha, Binita Dam, Abhik Dutta, Ravindra K. Zirmire, Edries Yousaf Hajam, Pankaj Kumar, Akash Gulyani, Colin Jamora
Sunny Kataria, Isha Rana, Krithika Badarinath, Rania F. Zaarour, Gaurav Kansagara, Sultan Ahmed, Abrar Rizvi, Dyuti Saha, Binita Dam, Abhik Dutta, Ravindra K. Zirmire, Edries Yousaf Hajam, Pankaj Kumar, Akash Gulyani, Colin Jamora
View: Text | PDF
Research Article Dermatology Inflammation

Mindin regulates fibroblast subpopulations through distinct Src family kinases during fibrogenesis

  • Text
  • PDF
Abstract

Fibrosis results from excessive extracellular matrix (ECM) deposition, which causes tissue stiffening and organ dysfunction. Activated fibroblasts, central to fibrosis, exhibit increased migration, proliferation, contraction, and ECM production. However, it remains unclear if the same fibroblast performs all of the processes that fall under the umbrella term of “activation.” Owing to fibroblast heterogeneity in connective tissues, subpopulations with specific functions may operate under distinct regulatory controls. Using a transgenic mouse model of skin fibrosis, we found that Mindin (also known as spondin-2), secreted by Snail-transgenic keratinocytes, differentially regulates fibroblast subpopulations. Mindin promotes migration and inflammatory gene expression in SCA1+ dermal fibroblasts via Fyn kinase. In contrast, it enhances contractility and collagen production in papillary CD26+ fibroblasts through c-Src signaling. Moreover, in the context of the fibrotic microenvironment of the tumor stroma, we found that differential responses of resident fibroblast subpopulations to Mindin extend to the generation of functionally heterogeneous cancer-associated fibroblasts. This study identifies Mindin as a key orchestrator of dermal fibroblast heterogeneity, reshaping cellular dynamics and signaling diversity in the complex landscapes of skin fibrosis and cancer.

Authors

Sunny Kataria, Isha Rana, Krithika Badarinath, Rania F. Zaarour, Gaurav Kansagara, Sultan Ahmed, Abrar Rizvi, Dyuti Saha, Binita Dam, Abhik Dutta, Ravindra K. Zirmire, Edries Yousaf Hajam, Pankaj Kumar, Akash Gulyani, Colin Jamora

×

Figure 4

Mindin induces fibroblast contraction and collagen production in CD26+ fibroblasts.

Options: View larger image (or click on image) Download as PowerPoint
Mindin induces fibroblast contraction and collagen production in CD26+ f...
(A) Measurement of intracellular distance between 2 nearest CD26+ nuclei (x axis) as a function of distance below the epidermis (y axis, bin number below the epidermis; bin size = 5 μm) in WT, SnTg, and SnTg/Min-KO skin (n = 3). (The number of CD26+ cells counted >80 in each section. The region shaded in gray marks the bins where P < 0.05, calculated using Welch’s t test.) (B) Collagen contraction assay, showing percentage of contraction of collagen gels seeded with mixed, CD26+, or SCA1+ fibroblasts and treated with either buffer control or Mindin (n ≥ 4). (C) Effect of SFK inhibition on Mindin-induced collagen contraction. CD26+ fibroblasts were treated with either buffer control or Mindin along with DMSO, PP2, or KbSrc4 (n ≥ 3). (D) Effect of nontargeting (NT), Src, Fyn, or Yes shRNA on collagen contraction with CD26+ fibroblasts treated with either buffer control or Mindin (n ≥ 3). (E) Measurement of the rate of closure (slope) in WT and Min-KO mice. The slope was calculated as the percentage of closure of a given day – the percentage of closure on the previous day (n = 3 mice, 2 wounds per mouse). (F) Quantification of COL1 in buffer control or Mindin-treated CD26+ and SCA1+ fibroblasts, normalized to Lamin B1 (LAM) (n = 4). Data represent the mean ± SEM. P values were calculated by Welch’s t test (B and E), ratio-paired t test (F), 1-way ANOVA followed by Tukey’s post hoc analysis (C), and 2-way ANOVA followed by post hoc Šídák’s multiple comparisons test (D). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; NS, P > 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts